These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 10651025)
21. MERRF/MELAS overlap syndrome: a double pathogenic mutation in mitochondrial tRNA genes. Nakamura M; Yabe I; Sudo A; Hosoki K; Yaguchi H; Saitoh S; Sasaki H J Med Genet; 2010 Oct; 47(10):659-64. PubMed ID: 20610441 [TBL] [Abstract][Full Text] [Related]
22. CPEO and carnitine deficiency overlapping in MELAS syndrome. Hsu CC; Chuang YH; Tsai JL; Jong HJ; Shen YY; Huang HL; Chen HL; Lee HC; Pang CY; Wei YH Acta Neurol Scand; 1995 Sep; 92(3):252-5. PubMed ID: 7484081 [TBL] [Abstract][Full Text] [Related]
23. Ocular pathology of MELAS syndrome with mitochondrial DNA nucleotide 3243 point mutation. Rummelt V; Folberg R; Ionasescu V; Yi H; Moore KC Ophthalmology; 1993 Dec; 100(12):1757-66. PubMed ID: 8259272 [TBL] [Abstract][Full Text] [Related]
24. Clinical features of MELAS and mitochondrial DNA mutations. Goto Y Muscle Nerve Suppl; 1995; 3():S107-12. PubMed ID: 7603510 [TBL] [Abstract][Full Text] [Related]
25. Tissue distribution of mutant mitochondrial DNA in mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Shoji Y; Sato W; Hayasaka K; Takada G J Inherit Metab Dis; 1993; 16(1):27-30. PubMed ID: 8487499 [TBL] [Abstract][Full Text] [Related]
26. Precipitation of stroke-like event by chickenpox in a child with MELAS syndrome. Jian-Ren L Neurol India; 2005 Sep; 53(3):323-5. PubMed ID: 16230801 [TBL] [Abstract][Full Text] [Related]
27. Cell cycle of myocytes of cardiac and skeletal muscle in mitochondrial myopathy. Takeda A; Chiba S; Takaaki I; Tanamura A; Yamaguchi Y; Takeda N Jpn Circ J; 1998 Sep; 62(9):695-9. PubMed ID: 9766710 [TBL] [Abstract][Full Text] [Related]
28. Secondary coenzyme Q10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts. Cotán D; Cordero MD; Garrido-Maraver J; Oropesa-Ávila M; Rodríguez-Hernández A; Gómez Izquierdo L; De la Mata M; De Miguel M; Lorite JB; Infante ER; Jackson S; Navas P; Sánchez-Alcázar JA FASEB J; 2011 Aug; 25(8):2669-87. PubMed ID: 21551238 [TBL] [Abstract][Full Text] [Related]
29. Mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes (MELAS): report of a sporadic case and review of the literature. Lee ML; Chaou WT; Yang AD; Jong YJ; Tsai JL; Pang CY; Wei YH Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1994; 35(2):148-56. PubMed ID: 8184691 [TBL] [Abstract][Full Text] [Related]
30. Clinical features of MELAS and its relation with A3243G gene point mutation. Zhang J; Guo J; Fang W; Jun Q; Shi K Int J Clin Exp Pathol; 2015; 8(10):13411-5. PubMed ID: 26722549 [TBL] [Abstract][Full Text] [Related]
31. Activation of the mitochondrial protein quality control system and actin cytoskeletal alterations in cells harbouring the MELAS mitochondrial DNA mutation. Felk S; Ohrt S; Kussmaul L; Storch A; Gillardon F J Neurol Sci; 2010 Aug; 295(1-2):46-52. PubMed ID: 20570288 [TBL] [Abstract][Full Text] [Related]
32. The 3260 mutation in mitochondrial DNA can cause mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS). Nishino I; Komatsu M; Kodama S; Horai S; Nonaka I; Goto Y Muscle Nerve; 1996 Dec; 19(12):1603-4. PubMed ID: 8941275 [No Abstract] [Full Text] [Related]
33. Temporal bone histopathological and quantitative analysis of mitochondrial DNA in MELAS. Takahashi K; Merchant SN; Miyazawa T; Yamaguchi T; McKenna MJ; Kouda H; Iino Y; Someya T; Tamagawa Y; Takiyama Y; Nakano I; Saito K; Boyer P; Kitamura K Laryngoscope; 2003 Aug; 113(8):1362-8. PubMed ID: 12897560 [TBL] [Abstract][Full Text] [Related]
34. Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Moraes CT; Ciacci F; Silvestri G; Shanske S; Sciacco M; Hirano M; Schon EA; Bonilla E; DiMauro S Neuromuscul Disord; 1993 Jan; 3(1):43-50. PubMed ID: 8392410 [TBL] [Abstract][Full Text] [Related]
35. Chorea-ballism as a dominant clinical manifestation in heteroplasmic mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome with A3251G mutation in mitochondrial genome: a case report. Lahiri D; Sawale VM; Banerjee S; Dubey S; Roy BK; Das SK J Med Case Rep; 2019 Mar; 13(1):63. PubMed ID: 30837005 [TBL] [Abstract][Full Text] [Related]
36. Heteroplasmic mitochondrial DNA mutation in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes. Chiang LM; Jong YJ; Huang SC; Tsai JL; Pang CY; Lee HC; Wei YH J Formos Med Assoc; 1995; 94(1-2):42-7. PubMed ID: 7613232 [TBL] [Abstract][Full Text] [Related]
37. Mitochondrial DNA mutations at nucleotide positions 3243 and 3271 in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: a comparative study. Sakuta R; Goto Y; Horai S; Nonaka I J Neurol Sci; 1993 Apr; 115(2):158-60. PubMed ID: 8482977 [TBL] [Abstract][Full Text] [Related]
38. Paralytic ileus in MELAS with phenotypic features of MNGIE. Chang TM; Chi CS; Tsai CR; Lee HF; Li MC Pediatr Neurol; 2004 Nov; 31(5):374-7. PubMed ID: 15519124 [TBL] [Abstract][Full Text] [Related]
39. Focal cerebellar infarction as an initial sign of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Ko A; Lee SJ; Lee YM J Inherit Metab Dis; 2019 May; 42(3):575-576. PubMed ID: 30693531 [TBL] [Abstract][Full Text] [Related]
40. Identification of a novel mutation in the mtDNA ND5 gene associated with MELAS. Santorelli FM; Tanji K; Kulikova R; Shanske S; Vilarinho L; Hays AP; DiMauro S Biochem Biophys Res Commun; 1997 Sep; 238(2):326-8. PubMed ID: 9299505 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]